## REVIEWER A — domain expert

This is a well-structured and transparent commissioning proposal. The approach is methodical, with clear success criteria, risk mitigation, and a realistic timeline. The prerequisite integrated demo on static beads provides a solid foundation, and the inclusion of a gating dynamic test before full approval is prudent. The PI’s prior system integrations add credibility, and the budget is lean and justified. Minor concerns: the AI agent has not yet been validated on dynamic biological samples, and the 7-day stress test is a stretch goal rather than a hard requirement. Overall, this project is highly feasible and de-risks a much larger investment.

| Criteria | Score |
|----------|-------|
| Impact | 4 |
| Approach | 5 |
| Innovation | 3 |
| Preliminary Data | 3 |
| PI & Team | 4 |
| Feasibility | 5 |
| Experimental Design | 5 |
| Budget | 4 |
| Clarity | 5 |
| Ethics | 5 |
| Overall | 4 |

**Score Sum: 47/55**

---

## REVIEWER B — fluff/impact auditor

The document is well-written but overstates its impact. The claim that a $4,656 investment reduces risk by 15–25% of an $80k project is plausible but unsubstantiated by hard data – no statistical evidence is provided. The project produces no new biological knowledge, only an engineering validation. The innovation is incremental (AI + microscopy is not new). The team is thin, and the PI’s prior integrations, while relevant, are not directly comparable to this AI-driven system. The budget is reasonable but the 20% contingency seems high relative to the small total. The experimental design is thorough, but the ultimate impact on the field is limited. This is an internal de‑risking exercise, not a fundable grant in its own right.

| Criteria | Score |
|----------|-------|
| Impact | 2 |
| Approach | 4 |
| Innovation | 2 |
| Preliminary Data | 2 |
| PI & Team | 3 |
| Feasibility | 4 |
| Experimental Design | 3 |
| Budget | 3 |
| Clarity | 4 |
| Ethics | 5 |
| Overall | 3 |

**Score Sum: 35/55**

---

## REVIEWER C — red team

While the proposal is admirably detailed and self‑reflective, it has several critical weaknesses. The AI agent’s performance on dynamic biological samples is unproven; the prerequisite demo on static beads does not demonstrate robustness to moving chloroplasts. The fallback rule‑based controller is mentioned but not described or validated – it is a placeholder. The safety watchdog test on agent‑generated unsafe commands is still planned, not executed. The PI lacks direct AI/ML expertise; the team relies on a single intern for data collection. The 7-day stress test stretch goal is unrealistic without prior long‑run data. The independent validation via human evaluation is a good step but subjective and could be confounded. Overall, the project is high‑risk and the evidence for success is insufficient to justify full funding at this stage.

| Criteria | Score |
|----------|-------|
| Impact | 2 |
| Approach | 3 |
| Innovation | 2 |
| Preliminary Data | 2 |
| PI & Team | 2 |
| Feasibility | 2 |
| Experimental Design | 3 |
| Budget | 3 |
| Clarity | 5 |
| Ethics | 5 |
| Overall | 2 |

**Score Sum: 31/55**

---

## Combined Verdict

**Combined Score: MIN = 31/55**  
**Recommendation: Major Revisions**  
**Top 3 Actions:**

1. **Complete and report the preliminary dynamic test on live *Elodea*** – the 10‑minute autonomous run is the single highest‑risk unknown; results must be submitted to reviewers before final approval.
2. **Validate the fallback rule‑based controller on dynamic samples** – provide a detailed description, benchmark it against the AI agent on moving chloroplasts, and confirm it can be deployed within 1 hour as claimed.
3. **Strengthen the AI agent reliability evidence** – execute the planned watchdog test with synthetic agent‑generated unsafe commands, and consider adding a blinded evaluation of the agent’s decisions on static bead data as an additional preliminary data point.